Paul Singer Is Betting on This Small Stock, You Should Too

Investing is extremely difficult if you are focusing on large-cap companies and their short-term performance. Even the smartest hedge fund managers can’t produce any meaningful alpha after taking into account their management and performance fees. On the other hand, investing is easy if you are focusing on small-cap companies and their long-term performance. In this article we will share an idea that is likely to beat the market by a large margin over the next couple of years.

Mitel

Mitel Networks Corporation (NASDAQ:MITL) has been a popular stock among hedge fund managers, with Jim Simons of Renaissance Technologies, Paul Singer of Elliot Management and Joseph A. Jolson of Harvest Capital Strategies holding a more than 1% stake in the Canadian communications company. Constantinos Christofilis, Peter Muller, and Josh Goldberg are also among hedge fund managers with positions in the stock at the end of the fourth quarter of 2013. We pay attention to what hedge funds are doing because our research has shown that the most popular stocks among hedge funds tend to outperform the market by a large margin on average (read the details here).

Mitel Networks Corporation (NASDAQ:MITL) is a $900 million market cap company that provides communication and collaboration software and services primarily to small-to-medium sized businesses (SMBs). Historically, it has been a profitable company with strong growth, high free cash flow generation and a track record of beating consensus estimates.

Mitel Networks Corporation (NASDAQ:MITL) recently completed its $370M acquisition of Canadian rival Aastra Technologies (TSX:AAH), expanding its market position in Canada (where MITL was already the leader before the deal) and Europe while providing a better platform for growth in the U.S. It also increases Mitel Networks Corporation (NASDAQ:MITL)’s global end user base to over 60M, expands its client base to larger enterprises, and combines two sales forces with minimal overlap. Financially, the transaction provides scale benefits (with combined revenue exceeding $1.0 billion), $50 million in low-risk run-rate synergies by 2016 (the vast majority of which will be realized by 2015), reduced net leverage and a strong cash flow profile. Given the extensive experience both companies’ management teams have in integrating acquisitions and realizing cost savings (four transactions were successfully completed by each company over the past several years), the synergy guidance could be conservative, in our view. It is worth noting that the present value of the $50 million in synergies on an after-tax basis is approximately $400M, which is roughly in-line with the combined increase in market values of the two companies since the deal was first announced on November 11, 2013. This implies investors believe management’s goals are achievable, while any further synergies, either on the revenue or cost side, would provide further upside for the stock.

Mitel Networks Corporation (NASDAQ:MITL)’s valuation looks reasonable, trading at an EV/EBITDA multiple of 9.2X, in-line with its peer group of communications equipment companies. Synergies related to the deal should aid Mitel Networks Corporation (NASDAQ:MITL)’s earnings over the next two to three years, which are admittedly not within the investment horizon of many shareholders, but any progress in realizing them should aid investor sentiment and, eventually, the multiple assigned to its earnings stream. Given the large size of the deal, successfully realizing synergies from the combined company will be the key driver of future stock performance. With strong track records of both management teams in integrating past acquisitions, we believe execution risk related to the Aastra deal is fairly low and shareholders will be rewarded over the long-term.

Disclosure: none

Recommended Reading:

Kurt Billick’s Bocage Capital Is Betting On These Stocks

Free Stock Research Report: Polycom Inc (PLCM)

Free Stock Research Report: Outerwall Inc (OUTR)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!